Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera vs Darbepoetin Alfa for Anemia in Hemodialysis
NCT00394953Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 14
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Dec 2006; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00394953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394953.